Nervous System Diseases Paediatrics intractable epilepsy
Conditions
Interventions
verapamil - Placebo
Control - non investigational meds
Sponsors
yasmin galal
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Age 5 - 15 years old Probable or definite localization-related, primary generalized or symptomatic generalized epilepsy that is medically-refractory, as defined by treatment failure of at least 2 anti-epilepsy drugs at standard doses, despite medication compliance as determined by the treating neurologist. Epileptic patients are considered controlled if they are seizure free for more than six months. Ability of the patient or gaurdian to understand the concept of a placebo-controlled clinical trial
Exclusion criteria
Exclusion criteria: Any patient with pre-existing cardiac condition. Low blood pressure as regard to the patient age, below 25th percentiles Known hypersensitivity to Verapamil or any component of the formulation. Patient with co-existing renal or hepatic illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| improved seizure control | — |
Countries
Egypt
Contacts
Public Contactrasha hussein
Ass. professor - medical school Ain shams university
Outcome results
None listed